Next Article in Journal
Experimental Analysis of Repaired Masonry Elements with Flax-FRCM and PBO-FRCM Composites Subjected to Axial Bending Loads
Next Article in Special Issue
Self-Folding Textiles through Manipulation of Knit Stitch Architecture
Previous Article in Journal / Special Issue
A Smart Shirt Made with Conductive Ink and Conductive Foam for the Measurement of Electrocardiogram Signals with Unipolar Precordial Leads
Article Menu

Export Article

Open AccessArticle
Fibers 2015, 3(4), 478-490; doi:10.3390/fib3040478

Biodegradable Nanofiber for Delivery of Immunomodulating Agent in the Treatment of Basal Cell Carcinoma

1
Department of Chemistry and Physics, La Trobe University, Bundoora, Victoria 3086, Australia
2
International Center for Materials Nanoarchitectonics (WPI-MANA), National Institute for Materials Science (NIMS), Tsukuba 305-0044, Japan
3
Graduate School of Pure and Applied Sciences, University of Tsukuba, Tsukuba 305-8571, Japan
4
Department of Material Science and Technology, Graduate School of Tokyo, University of Science, Tokyo 278-8510, Japan
*
Author to whom correspondence should be addressed.
Academic Editor: Jinlian Hu
Received: 30 September 2015 / Accepted: 30 October 2015 / Published: 6 November 2015
(This article belongs to the Special Issue Smart Textiles)
View Full-Text   |   Download PDF [617 KB, uploaded 10 November 2015]   |  

Abstract

In this paper we investigate a potential new treatment option for basal cell carcinoma using electrospun polymer nanofibers. Poly(ε-caprolactone) fibers incorporated with the anti-cancer drug imiquimod were successfully produced for the first time. These fibers were characterized and their diffusion release profile tested in vitro. A range of different electrospinning parameters were investigated in order to determine the most effective approach in optimizing the fibers for future in vivo testing. Characterization showed stable and homogeneous distribution of imiquimod. Although the drug was released faster than what would be needed to replicate the current treatment model, this system would ideally allow for a treatment option which reduces side effects and is more convenient for the patient than the current topical treatment. View Full-Text
Keywords: biodegradable nanofiber; poly(ε-caprolactone); imiquimod; anti-cancer fiber biodegradable nanofiber; poly(ε-caprolactone); imiquimod; anti-cancer fiber
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Garrett, R.; Niiyama, E.; Kotsuchibashi, Y.; Uto, K.; Ebara, M. Biodegradable Nanofiber for Delivery of Immunomodulating Agent in the Treatment of Basal Cell Carcinoma. Fibers 2015, 3, 478-490.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Fibers EISSN 2079-6439 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top